Option Care Health, Inc. (OPCH)
USD 22.78
(-2.73%)
USD 22.78
(-2.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.9 Billion USD | 10.41% |
| 2022 | 1.72 Billion USD | 6.92% |
| 2021 | 1.61 Billion USD | -1.02% |
| 2020 | 1.63 Billion USD | -3.03% |
| 2019 | 1.68 Billion USD | 131.16% |
| 2018 | 727.94 Million USD | 5.96% |
| 2017 | 686.98 Million USD | 7.46% |
| 2016 | 639.3 Million USD | 1.9% |
| 2015 | 627.38 Million USD | 3.2% |
| 2014 | 607.9 Million USD | 4.4% |
| 2013 | 582.27 Million USD | 66.86% |
| 2012 | 348.96 Million USD | -24.44% |
| 2011 | 461.82 Million USD | -0.44% |
| 2010 | 463.88 Million USD | 252.96% |
| 2009 | 131.42 Million USD | -13.2% |
| 2008 | 151.42 Million USD | 15.92% |
| 2007 | 130.61 Million USD | -9.05% |
| 2006 | 143.62 Million USD | 54.73% |
| 2005 | 92.82 Million USD | 31.12% |
| 2004 | 70.78 Million USD | 10.63% |
| 2003 | 63.98 Million USD | -27.3% |
| 2002 | 88.02 Million USD | 10.69% |
| 2001 | 79.52 Million USD | 4.93% |
| 2000 | 75.78 Million USD | -4.53% |
| 1999 | 79.38 Million USD | 13.57% |
| 1998 | 69.9 Million USD | 56.03% |
| 1997 | 44.8 Million USD | 46.41% |
| 1996 | 30.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.93 Billion USD | 6.41% |
| 2024 Q3 | 2 Billion USD | 3.32% |
| 2024 Q1 | 1.82 Billion USD | -4.52% |
| 2023 FY | 1.9 Billion USD | 10.41% |
| 2023 Q1 | 1.78 Billion USD | 3.09% |
| 2023 Q4 | 1.9 Billion USD | 5.72% |
| 2023 Q3 | 1.8 Billion USD | -2.27% |
| 2023 Q2 | 1.84 Billion USD | 3.67% |
| 2022 Q1 | 1.65 Billion USD | 2.57% |
| 2022 FY | 1.72 Billion USD | 6.92% |
| 2022 Q2 | 1.7 Billion USD | 2.68% |
| 2022 Q4 | 1.72 Billion USD | -0.52% |
| 2022 Q3 | 1.73 Billion USD | 2.06% |
| 2021 Q3 | 1.68 Billion USD | 1.6% |
| 2021 Q1 | 1.62 Billion USD | -0.57% |
| 2021 FY | 1.61 Billion USD | -1.02% |
| 2021 Q4 | 1.61 Billion USD | -4.36% |
| 2021 Q2 | 1.66 Billion USD | 2.45% |
| 2020 Q2 | 1.75 Billion USD | 0.93% |
| 2020 Q1 | 1.74 Billion USD | 3.53% |
| 2020 Q3 | 1.67 Billion USD | -4.74% |
| 2020 FY | 1.63 Billion USD | -3.03% |
| 2020 Q4 | 1.63 Billion USD | -2.58% |
| 2019 Q1 | 753.53 Million USD | 3.52% |
| 2019 FY | 1.68 Billion USD | 131.16% |
| 2019 Q3 | 1.66 Billion USD | 114.2% |
| 2019 Q2 | 775.1 Million USD | 2.86% |
| 2019 Q4 | 1.68 Billion USD | 1.35% |
| 2018 FY | 727.94 Million USD | 5.96% |
| 2018 Q4 | 727.94 Million USD | 3.13% |
| 2018 Q1 | 687.09 Million USD | 0.02% |
| 2018 Q2 | 683.11 Million USD | -0.58% |
| 2018 Q3 | 705.86 Million USD | 3.33% |
| 2017 Q2 | 676.87 Million USD | 4.09% |
| 2017 Q4 | 686.98 Million USD | 2.8% |
| 2017 Q1 | 650.27 Million USD | 1.72% |
| 2017 FY | 686.98 Million USD | 7.46% |
| 2017 Q3 | 668.24 Million USD | -1.27% |
| 2016 FY | 639.3 Million USD | 1.9% |
| 2016 Q1 | 595.01 Million USD | -5.16% |
| 2016 Q4 | 639.3 Million USD | 3.17% |
| 2016 Q3 | 619.68 Million USD | 10.4% |
| 2016 Q2 | 561.32 Million USD | -5.66% |
| 2015 Q2 | 620.44 Million USD | -3.24% |
| 2015 Q1 | 641.19 Million USD | 5.48% |
| 2015 FY | 627.38 Million USD | 3.2% |
| 2015 Q4 | 627.38 Million USD | 0.58% |
| 2015 Q3 | 623.79 Million USD | 0.54% |
| 2014 Q3 | 580.31 Million USD | 2.02% |
| 2014 Q1 | 567.42 Million USD | -2.55% |
| 2014 Q4 | 607.9 Million USD | 4.75% |
| 2014 FY | 607.9 Million USD | 4.4% |
| 2014 Q2 | 568.8 Million USD | 0.24% |
| 2013 Q2 | 345.8 Million USD | -8.58% |
| 2013 Q3 | 555.96 Million USD | 60.77% |
| 2013 FY | 582.27 Million USD | 66.86% |
| 2013 Q1 | 378.24 Million USD | 8.39% |
| 2013 Q4 | 582.27 Million USD | 4.73% |
| 2012 Q4 | 348.96 Million USD | -6.52% |
| 2012 Q1 | 459.36 Million USD | -0.53% |
| 2012 FY | 348.96 Million USD | -24.44% |
| 2012 Q2 | 380.01 Million USD | -17.27% |
| 2012 Q3 | 373.29 Million USD | -1.77% |
| 2011 FY | 461.82 Million USD | -0.44% |
| 2011 Q4 | 461.82 Million USD | 3.91% |
| 2011 Q3 | 444.43 Million USD | 0.74% |
| 2011 Q2 | 441.17 Million USD | -1.15% |
| 2011 Q1 | 446.3 Million USD | -3.79% |
| 2010 Q2 | 457.05 Million USD | -1.49% |
| 2010 Q4 | 463.88 Million USD | -2.97% |
| 2010 Q3 | 478.06 Million USD | 4.6% |
| 2010 FY | 463.88 Million USD | 252.96% |
| 2010 Q1 | 463.97 Million USD | 253.03% |
| 2009 Q2 | 127.27 Million USD | -0.26% |
| 2009 Q1 | 127.61 Million USD | -15.72% |
| 2009 Q4 | 131.42 Million USD | 3.1% |
| 2009 FY | 131.42 Million USD | -13.2% |
| 2009 Q3 | 127.47 Million USD | 0.16% |
| 2008 Q2 | 149.08 Million USD | 0.39% |
| 2008 Q3 | 165.33 Million USD | 10.9% |
| 2008 Q4 | 151.42 Million USD | -8.42% |
| 2008 FY | 151.42 Million USD | 15.92% |
| 2008 Q1 | 148.5 Million USD | 13.69% |
| 2007 Q4 | 130.61 Million USD | 0.61% |
| 2007 Q3 | 129.82 Million USD | -6.65% |
| 2007 Q2 | 139.07 Million USD | -8.49% |
| 2007 Q1 | 151.97 Million USD | 5.82% |
| 2007 FY | 130.61 Million USD | -9.05% |
| 2006 FY | 143.62 Million USD | 54.73% |
| 2006 Q2 | 119.91 Million USD | 4.01% |
| 2006 Q3 | 114.7 Million USD | -4.34% |
| 2006 Q1 | 115.28 Million USD | 24.2% |
| 2006 Q4 | 143.62 Million USD | 25.21% |
| 2005 Q3 | 72.8 Million USD | -0.81% |
| 2005 Q4 | 92.82 Million USD | 27.49% |
| 2005 Q2 | 73.4 Million USD | -10.74% |
| 2005 Q1 | 82.24 Million USD | 16.18% |
| 2005 FY | 92.82 Million USD | 31.12% |
| 2004 FY | 70.78 Million USD | 10.63% |
| 2004 Q3 | 65.08 Million USD | -3.73% |
| 2004 Q2 | 67.6 Million USD | -8.93% |
| 2004 Q1 | 74.24 Million USD | 16.02% |
| 2004 Q4 | 70.78 Million USD | 8.76% |
| 2003 FY | 63.98 Million USD | -27.3% |
| 2003 Q4 | 63.98 Million USD | -1.94% |
| 2003 Q1 | 85.71 Million USD | -2.62% |
| 2003 Q2 | 79.75 Million USD | -6.96% |
| 2003 Q3 | 65.25 Million USD | -18.17% |
| 2002 FY | 88.02 Million USD | 10.69% |
| 2002 Q3 | 88.62 Million USD | -14.76% |
| 2002 Q2 | 103.97 Million USD | -4.34% |
| 2002 Q4 | 88.02 Million USD | -0.68% |
| 2002 Q1 | 108.69 Million USD | 36.69% |
| 2001 Q4 | 79.52 Million USD | 3.42% |
| 2001 Q2 | 77.59 Million USD | -5.05% |
| 2001 Q1 | 81.71 Million USD | 7.83% |
| 2001 FY | 79.52 Million USD | 4.93% |
| 2001 Q3 | 76.89 Million USD | -0.9% |
| 2000 Q4 | 75.78 Million USD | 5.14% |
| 2000 Q1 | 80.34 Million USD | 1.21% |
| 2000 Q2 | 77.96 Million USD | -2.96% |
| 2000 Q3 | 72.07 Million USD | -7.55% |
| 2000 FY | 75.78 Million USD | -4.53% |
| 1999 FY | 79.38 Million USD | 13.57% |
| 1999 Q2 | 62.9 Million USD | 6.43% |
| 1999 Q3 | 83.4 Million USD | 32.59% |
| 1999 Q4 | 79.38 Million USD | -4.82% |
| 1999 Q1 | 59.1 Million USD | -15.45% |
| 1998 Q4 | 69.9 Million USD | 8.2% |
| 1998 Q3 | 64.6 Million USD | 26.67% |
| 1998 FY | 69.9 Million USD | 56.03% |
| 1998 Q1 | 44.3 Million USD | -1.12% |
| 1998 Q2 | 51 Million USD | 15.12% |
| 1997 Q1 | 30.1 Million USD | -1.63% |
| 1997 Q3 | 28.9 Million USD | 17.48% |
| 1997 Q4 | 44.8 Million USD | 55.02% |
| 1997 FY | 44.8 Million USD | 46.41% |
| 1997 Q2 | 24.6 Million USD | -18.27% |
| 1996 Q3 | 32.4 Million USD | 0.0% |
| 1996 FY | 30.6 Million USD | 0.0% |
| 1996 Q4 | 30.6 Million USD | -5.56% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 22.843% |
| Addus HomeCare Corporation | 317.73 Million USD | -500.091% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -1371.659% |
| Amedisys, Inc. | 940.38 Million USD | -102.755% |
| American Oncology Network, Inc. | 368.72 Million USD | -417.1% |
| Astrana Health, Inc. | 522.59 Million USD | -264.85% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | -8.052% |
| IMAC Holdings, Inc. | 1.89 Million USD | -100422.785% |
| biote Corp. | 191.84 Million USD | -893.887% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -2538.933% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -825.915% |
| COMPASS Pathways plc | 50.24 Million USD | -3694.921% |
| DocGo Inc. | 185.28 Million USD | -929.076% |
| The Ensign Group, Inc. | 2.68 Billion USD | 28.861% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -450.164% |
| InnovAge Holding Corp. | 247.85 Million USD | -669.279% |
| Assure Holdings Corp. | 22.84 Million USD | -8244.707% |
| The Joint Corp. | 62.37 Million USD | -2956.61% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -137.068% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -49928.889% |
| ModivCare Inc. | 1.61 Billion USD | -18.348% |
| NewGenIvf Group Limited | 1.24 Million USD | -153486.938% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -17133.25% |
| P3 Health Partners Inc. | 427.3 Million USD | -346.211% |
| P3 Health Partners Inc. | 427.3 Million USD | -346.211% |
| The Pennant Group, Inc. | 394.17 Million USD | -383.713% |
| Surgery Partners, Inc. | 3.65 Billion USD | 47.865% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -209408.918% |
| Talkspace, Inc. | 23.57 Million USD | -7987.729% |
| Talkspace, Inc. | 23.57 Million USD | -7987.729% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1074.116% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1074.116% |